Ligand Pharmaceuticals, Inc. (LGND)

CAPS Rating:

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.